FI952196A0 - Framstaellning av immunoglobulin - Google Patents

Framstaellning av immunoglobulin

Info

Publication number
FI952196A0
FI952196A0 FI952196A FI952196A FI952196A0 FI 952196 A0 FI952196 A0 FI 952196A0 FI 952196 A FI952196 A FI 952196A FI 952196 A FI952196 A FI 952196A FI 952196 A0 FI952196 A0 FI 952196A0
Authority
FI
Finland
Prior art keywords
treated
immunoglobulin
pepsin
immunoglobulin production
products
Prior art date
Application number
FI952196A
Other languages
English (en)
Inventor
Hammu Veli Herman Suomela
Eero Olavi Haemaelaeinen
Original Assignee
Suomen Punainen Risti Veripalv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suomen Punainen Risti Veripalv filed Critical Suomen Punainen Risti Veripalv
Priority to FI952196A priority Critical patent/FI952196A0/fi
Publication of FI952196A0 publication Critical patent/FI952196A0/fi
Priority to DE69627319T priority patent/DE69627319T2/de
Priority to EP96913551A priority patent/EP0825998B1/en
Priority to AU56500/96A priority patent/AU700736B2/en
Priority to DK96913551T priority patent/DK0825998T3/da
Priority to PCT/FI1996/000254 priority patent/WO1996035710A1/en
Priority to AT96913551T priority patent/ATE236926T1/de
Priority to US08/952,199 priority patent/US20020128453A1/en
Priority to JP8533805A priority patent/JPH11504644A/ja
Priority to US10/635,859 priority patent/US20040106780A1/en
Priority to US11/231,358 priority patent/US20060177909A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0017—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/022—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • C12N7/06—Inactivation or attenuation by chemical treatment
FI952196A 1995-05-08 1995-05-08 Framstaellning av immunoglobulin FI952196A0 (fi)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FI952196A FI952196A0 (fi) 1995-05-08 1995-05-08 Framstaellning av immunoglobulin
JP8533805A JPH11504644A (ja) 1995-05-08 1996-05-07 免疫グロブリンの製造
DK96913551T DK0825998T3 (da) 1995-05-08 1996-05-07 Fremstilling af immunoglobulin
EP96913551A EP0825998B1 (en) 1995-05-08 1996-05-07 Preparation of immunoglobulin
AU56500/96A AU700736B2 (en) 1995-05-08 1996-05-07 Preparation of immunoglobulin
DE69627319T DE69627319T2 (de) 1995-05-08 1996-05-07 Herstellung von immunglobulin
PCT/FI1996/000254 WO1996035710A1 (en) 1995-05-08 1996-05-07 Preparation of immunoglobulin
AT96913551T ATE236926T1 (de) 1995-05-08 1996-05-07 Herstellung von immunglobulin
US08/952,199 US20020128453A1 (en) 1995-05-08 1996-05-07 Preparation of immunoglobulin
US10/635,859 US20040106780A1 (en) 1995-05-08 2003-08-06 Preparation of immunoglobulin
US11/231,358 US20060177909A1 (en) 1995-05-08 2005-09-20 Preparation of immunoglobulin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI952196A FI952196A0 (fi) 1995-05-08 1995-05-08 Framstaellning av immunoglobulin

Publications (1)

Publication Number Publication Date
FI952196A0 true FI952196A0 (fi) 1995-05-08

Family

ID=8543365

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952196A FI952196A0 (fi) 1995-05-08 1995-05-08 Framstaellning av immunoglobulin

Country Status (9)

Country Link
US (3) US20020128453A1 (fi)
EP (1) EP0825998B1 (fi)
JP (1) JPH11504644A (fi)
AT (1) ATE236926T1 (fi)
AU (1) AU700736B2 (fi)
DE (1) DE69627319T2 (fi)
DK (1) DK0825998T3 (fi)
FI (1) FI952196A0 (fi)
WO (1) WO1996035710A1 (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6267798A (en) 1997-02-07 1998-08-26 Stryker Corporation Matrix-free osteogenic devices, implants and methods of use thereof
CA2232420A1 (en) * 1997-03-19 1998-09-19 The Green Cross Corporation Immunoglobulin preparation and preparation process thereof
GB9705810D0 (en) 1997-03-20 1997-05-07 Common Services Agency Intravenous immune globulin
US7041641B2 (en) 1997-03-20 2006-05-09 Stryker Corporation Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
AT405608B (de) * 1997-04-08 1999-10-25 Immuno Ag Verfahren zur inaktivierung von pathogenen, insbesondere von viren, in einem biologischen material
CA2285935C (en) 1997-04-08 2011-01-18 Baxter Aktiengesellschaft An immunotolerant prothrombin complex preparation
AT406873B (de) * 1998-02-25 2000-10-25 Immuno Ag Verfahren zur abreicherung von pathogenen aus proteinhaltigen lösungen
WO2004024752A1 (ja) 2002-09-11 2004-03-25 Chugai Seiyaku Kabushiki Kaisha タンパク質精製方法
TWI320788B (en) 2005-05-25 2010-02-21 Hoffmann La Roche Method for the purification of antibodies
US20070128693A1 (en) * 2005-12-06 2007-06-07 Advantek Serum Laboratories Limited3/F Method for the inactivation and removal of dengue virus from biological samples
JP4857323B2 (ja) * 2008-10-17 2012-01-18 田辺三菱製薬株式会社 免疫グロブリン製剤
EP3275897A1 (en) 2016-07-27 2018-01-31 Biotest AG Process for preparing immunoglobulin compositions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966906A (en) * 1961-10-11 1976-06-29 Behringwerke Aktiengesellschaft Disaggregated gamma globulin and process for preparing it
JPS57206608A (en) * 1981-05-29 1982-12-18 Mochida Pharmaceut Co Ltd Production of gamma-globulin for intravenous injection
US4591505A (en) * 1982-04-14 1986-05-27 New York Blood Center, Inc. Process for inactivating hepatitis B virus
US4481189A (en) * 1982-04-14 1984-11-06 New York Blood Center Inc. Process for preparing sterilized plasma and plasma derivatives
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
US4613501A (en) * 1984-12-21 1986-09-23 New York Blood Center, Inc. Inactivation of viruses in labile blood derivatives
FR2582515B1 (fr) * 1985-05-30 1988-11-04 Merieux Inst Procede de preparation de gamma-gobulines administrables par voie intraveineuse et gamma-globulines obtenues
GB8628104D0 (en) * 1986-11-25 1986-12-31 Connaught Lab Pasteurization of immunoglobin solutions
US5118796A (en) * 1987-12-09 1992-06-02 Centocor, Incorporated Efficient large-scale purification of immunoglobulins and derivatives
DE69011136T3 (de) * 1989-01-13 2003-10-23 Mitsubishi Pharma Corp Verfahren zur Herstellung einer Protein enthaltenden Zusammensetzung.
JPH0778025B2 (ja) * 1990-03-20 1995-08-23 日本赤十字社 免疫グロブリンｇの製造方法
US5506127A (en) * 1994-09-21 1996-04-09 Proba; Zbigniew Therapeutic grade thrombin produced by chromatography

Also Published As

Publication number Publication date
DE69627319D1 (de) 2003-05-15
US20060177909A1 (en) 2006-08-10
DK0825998T3 (da) 2003-08-04
DE69627319T2 (de) 2004-02-12
EP0825998A1 (en) 1998-03-04
WO1996035710A1 (en) 1996-11-14
EP0825998B1 (en) 2003-04-09
AU5650096A (en) 1996-11-29
US20040106780A1 (en) 2004-06-03
AU700736B2 (en) 1999-01-14
ATE236926T1 (de) 2003-04-15
JPH11504644A (ja) 1999-04-27
US20020128453A1 (en) 2002-09-12

Similar Documents

Publication Publication Date Title
FI952196A0 (fi) Framstaellning av immunoglobulin
ATE193020T1 (de) Verfahren zur herstellung von immunoglobulin g konzentrat
DE69428130T2 (de) Verwendung von bcl-2 zur herstellung von arzneimitteln zur therapeutischen behandlung und verhinderung von krankheiten
EP0680764A3 (en) Stable preparation for the treatment of blood coagulation disorders, comprising an activated coagulation factor and lipid vesicles
DE69308311D1 (de) Methode zur reinigung von metallhaltigen wässrigen flüssigkeiten und methode zur herstellung eines adsorbens
ATE330970T1 (de) Neue anti-hiv immunogene (toxoide), herstellungsverfahren und verwendungen zur behandlung und vorbeugung von aids
DE69311260D1 (de) Verfahren zur Herstellung von (E)-Alkoximino- oder Hydroxyiminoacetamidverbindungen und Zwischenprodukte
ATE307203T1 (de) Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma
DE69613597D1 (de) Verfahren zur Herstellung von Cyclopentadienyl-Verbindungen und nach dem Verfahren hergestellte Verbindungen
EA199800685A1 (ru) Разделение компонентов плазмы крови с помощью фильтрующих средств на основе целлюлозы
FR2772381B1 (fr) Procede de preparation par filtration d'une solution de facteur viii securisee viralement
ATE251087T1 (de) Verfahren zur herstellung von pulverförmigen heterogenen stoffen
DE69619187D1 (de) Verfahren zur behandlung von motorischen defiziten
DE3874376D1 (de) Verfahren zur herstellung eines konzentrates von alpha-1-antitrypsin von menschlicher plasmafraktion und seine verwendung als arzneimittel.
DE3787437T2 (de) Sialosylcholesterol, verfahren zu dessen herstellung und arzneimittel zur behandlung von krankheiten des nervensystems.
DE69328102T2 (de) Verwendung von gift aus hautflüglern (hymenopteren) zur herstellung eines medikamentes zur behandlung von infektionen durch dna-viren
ATE357914T1 (de) Verwendung von 4-aminopyridin zur behandlung von peripheren neuropathien
DE68928634T2 (de) Verfahren zur Herstellung von aktivierten Killer-Monozyten und Verfahren zur Überprüfung ihrer tumoriziden Aktivität
DE69424415D1 (de) Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit
DE69610045T2 (de) Verwendung eines Rohpflanzenextraktes zur Herstellung eines Arzneimittels zur Behandlung von HIV-Infektionen
DE69310343D1 (de) Blutverarbeitungssysteme mit verbesserter ausbeute und methoden zur herstellung von vortexströmungsbedingungen
DE69420425D1 (de) Die Herstellung von 3-Alkylamino-2-Piperazinylpyridinen
DE69932741D1 (de) Verwendung von n-glycolneuraminsäure und deren derivaten zur herstellung eines medikaments zur behandlung von hiv-infektionen
DE3680329D1 (de) Methode zur herstellung von dekorativen emblemen und dergleichen sowie auf diese weise hergestellte gegenstaende.
DE68913932T2 (de) Arzneimittel für die Behandlung oder die Verhütung von Infektionen mit HIV durch Immunisierung, und Verfahren zur Herstellung.

Legal Events

Date Code Title Description
FD Application lapsed